#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Cholangiosarcoma Facioscapulohumeral muscular dystrophy B-cell lymphoma Haemolytic uraemic syndrome Cerebral amyloid angiopathy Peripheral T-cell lymphoma unspecified Epilepsy with myoclonic-atonic seizures Hidradenitis Retinoblastoma Anti-neutrophil cytoplasmic antibody positive vasculitis Glomerulonephritis rapidly progressive Non-renal cell carcinoma of kidney Glycogen storage disease type V Desmoplastic small round cell tumour More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Trials in Disease Propionic acidaemia – Basic Information Lymphangioma – Treatment Marginal zone lymphoma refractory – Basic Information Mantle cell lymphoma stage II – Diagnostics Hepatoblastoma – Basic Information Antithrombin III deficiency – Treatment Alport’s syndrome – Treatment Inclusion body myositis Congenital generalised lipodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lonvoguran Busulfan ZUNIBERGENE ROCPARVOVEC Bi-1808 Moxifloxacin Ceftolozane Sitagliptin SODIUM SULFIDE NONAHYDRATE Sapropterin Dihydrochloride E2814 Levosimendan Flutafuranol (18F) Bcmacp03 Clavulanic Acid Edotreotide Magnesium F44/10 Sodium Alginate Trientine Dihydrochloride GSKVX000000034794 More therapies…

    Learn about Your Condition

    Plasma cell myeloma Traumatic pain Embolism Benign neoplasm of ureter Colorectal cancer Glomerulonephritis membranous Oesophagogastroscopy Testicular germ cell tumour Polycystic liver disease Nephropathy Bone hypertrophy Thymic carcinoma Infertility female Breast cancer stage I Paget's disease of the vulva More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Gemcitabine Hydrochloride for Patients with Low Grade Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Gemcitabine Hydrochloride
    Austria

  • Study on Colchicine and Thiamine for Patients with Heart Failure from Ischemic Heart Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    • Thiamine Hydrochloride
    Italy

  • Study of acetylsalicylic acid to prevent stroke in patients undergoing brain aneurysm coiling procedure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Lactose Monohydrate
    • Acetylsalicylic Acid
    France

  • Study on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption

    Recruiting

    3 1
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden

  • Study on Optimal Dose of Rabbit Anti-Human T-Lymphocyte Immunoglobulin and Mycophenolic Acid for Kidney Transplant Patients with Low Immunological Risk

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Mycophenolic Acid
    France

  • Study on the Effectiveness and Safety of Etanercept for Patients with SAPHO Syndrome

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • SAPHO syndrome
    Investigated Drugs:
    • Water For Injections
    • Etanercept
    Poland
Previous Page
1 … 397 398 399 400 401 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!